X

 

Effective November 29, 2022, Viatris completed the sale of substantially all of its biosimilars portfolio (including related product trademarks) to Biocon Biologics Limited and its subsidiaries (“Biocon”) and the relevant marketing authorizations are in process of being transferred. Viatris Inc. and its subsidiaries (“Viatris”) are not affiliates of Biocon but are providing certain transition services to Biocon following the transaction completion date, such as operating websites (including this site) relating to the biosimilars portfolio on Biocon’s behalf.

Savings and Support

Savings and Support

VIATRISTM offers a savings program for SEMGLEE and Insulin Glargine (insulin glargine-yfgn) injection. These savings cards help eligible patients who have commercial health insurance save on out-of-pocket costs.

 

Savings Card

This savings card is not available to uninsured patients or patients
who are covered by a state or federal funded healthcare program.
Restrictions apply. Please see full terms and conditions here.

The SEMGLEE Savings Card:  

  • Image of Card
    Eligible patients with commercial health insurance may pay as little as $0 up to $94 per 30-day for SEMGLEE or Insulin Glargine (insulin glargine-yfgn). Savings may vary depending upon your out-of-pocket costs.  
  • Computer Monitor Icon
    Print the offer from your computer or save it to your smartphone, and simply present it to your pharmacist each time you drop off or refill your prescription.

Enroll now

Group of People

VIATRIS PATIENT ASSISTANCE PROGRAM

  • Patients without insurance coverage for their SEMGLEE or Insulin Glargine (insulin glargine-yfgn) prescription who cannot afford their medication might be eligible to receive their medication free of charge (subject to eligibility criteria)
  • The Continuing Need State Insulin Program (administered through the Viatris Patient Assistance Program) provides SEMGLEE or Insulin Glargine (insulin glargine-yfgn) to eligible patients for up to 12 months during the patient’s enrollment in the Program (eligibility and restrictions apply as required by the applicable State Insulin Affordability/Safety Net Program law). For more information on the Continuing Need State Insulin Program, click here and select your applicable insulin product from the Patient Assistance Program Medicines drop down menu to obtain an application
  • For more information on patient assistance resources, contact VIATRIS at 1-800-796-9526 or customer.service@viatris.com
Clipboard Icon with People

DIABETES SUPPORT AND OUTREACH

Since 2013, the list prices of some insulins have skyrocketed in the United States. People who do not have health insurance, or those who are on high-deductible insurance plans, may have to pay out-of-pocket costs up to $1,000 for a one-month supply of insulin.2

There are many organizations with a mission to help patients and caregivers affected by diabetes.

Scroll down to learn more about two of them, GetInsulin.org and Beyond Type 1, which may help you connect with outreach programs, community platforms, and financial assistance options.2

BEYOND TYPE 1

  • Globe Icon with PeopleBeyond Type 1 is a nonprofit organization dedicated to changing what it means to live with diabetes through its platforms, programs, and helpful resources.3
  • Hand Icon with Blood Glucose Monitor and Test StripFounded in 2015 with a focus on education, advocacy, and the path to a cure for type 1 diabetes, Beyond Type 1 has grown to also include programs for those with type 2 diabetes. A new model of philanthropy, Beyond Type 1 aims to change what it means to live with this chronic condition.3
  • Network of PeopleBeyond Type 1 is also devoted to connecting people with diabetes to assistance programs and to low-cost solutions that match every unique situation.3

Learn more

GETINSULIN.ORG

  • Image of Insulin Syringe and Prefilled SyringeGetInsulin.org connects people with diabetes in the United States to affordable insulin options that match all unique circumstances. This app is an important tool for people who need help paying for their insulin, regardless of the medication brand.2
  • Image of Q and A SymbolUsers only need to answer a few simple questions (such as location, insurance type, income, and prescription), to access customized action plans and financial solutions.2
  • United States IconApp content in the site is available in both English and Spanish and is tailored specifically to people with diabetes in the United States.2

Learn more

References:

  1. SEMGLEE (insulin glargine-yfgn) injection 100 units/mL (U-100). Copay Program.
     https://www.semgleehcp.com/en/savings
  2. GETINSULIN.ORG. Accessed October 25, 2021. https://getinsulin.org/about/
  3. BeyondType1.org. Accessed October 25, 2021. https://beyondtype1.org/
Product Logo

Instructions For Use

Please select from the following:

CLOSE

SEMGLEE and the Semglee Logo are registered trademarks of Mylan Pharmaceuticals Inc., a Viatris Company.
VIATRIS ADVOCATE and the Viatris Advocate Logo are registered trademarks of Mylan Pharmaceuticals Inc., a Viatris Company.
VIATRIS and the Viatris Logo are trademarks of Mylan Inc., a Viatris Company.
LOYALTYSCRIPT is a trademark of McKesson Corporation.
LANTUS is a registered trademark of Sanofi-Aventis.
© 2023 Viatris Inc. All Rights Reserved.
SEMI-2021-0008 V3

Company Logo
MORE LESS

IMPORTANT SAFETY INFORMATION

(This information also applies to Insulin Glargine (insulin glargine-yfgn) injection)

What is SEMGLEE (insulin glargine-yfgn) injection 100 Units/mL?

SEMGLEE is a prescription long-acting man-made-insulin used to control high blood sugar in adults and children with type 1 diabetes and in adults with type 2 diabetes.

  • SEMGLEE is not for use to treat diabetic ketoacidosis.

It is not known if SEMGLEE is safe and effective in children less than 6 years of age with type 1 diabetes.

IMPORTANT SAFETY INFORMATION

(This information also applies to Insulin Glargine (insulin glargine-yfgn) injection)

What is SEMGLEE (insulin glargine-yfgn) injection 100 Units/mL?

SEMGLEE is a prescription long-acting man-made-insulin used to control high blood sugar in adults and children with type 1 diabetes and in adults with type 2 diabetes.

  • SEMGLEE is not for use to treat diabetic ketoacidosis.

It is not known if SEMGLEE is safe and effective in children less than 6 years of age with type 1 diabetes.

IMPORTANT SAFETY INFORMATION

Do not share your pen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.

Do not use SEMGLEE during episodes of low blood sugar or if you are allergic to insulin glargine or any of the ingredients in SEMGLEE.

Do not share needles, insulin pens, or syringes with others. Do NOT reuse needles.

Before using SEMGLEE, tell your healthcare provider about all your medical conditions including if you:

  • have liver or kidney problems.
  • take other medicines, especially ones called TZDs (thiazolidinediones).
  • have heart failure or other heart problems. If you have heart failure, it may get worse while you take TZDs with SEMGLEE.
  • are pregnant, planning to become pregnant, or are breastfeeding. It is not known if SEMGLEE may harm your unborn baby or breastfeeding baby.

Tell your healthcare provider about all the medicines you take including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Before you start using SEMGLEE, talk to your healthcare provider about low blood sugar and how to manage it.

Change (rotate) your injection sites within the area you chose with each dose to reduce your risk of getting lipodystrophy (pitted or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites. Do not use the same spot for each injection or inject where the skin is pitted, thickened, lumpy, tender, bruised, scaly, hard, scarred or damaged. Tell your doctor if you have any new or worsening symptoms of heart failure, including shortness of breath, swelling of your ankles or feet, sudden weight gain.

SEMGLEE should be taken once a day at the same time every day. Test your blood sugar levels while using insulin, such as SEMGLEE. Do not make any changes to your dose or type of insulin without talking to your healthcare provider. Any change of insulin should be made cautiously and only under medical supervision.

Do NOT dilute or mix SEMGLEE with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. SEMGLEE must only be used if the solution is clear and colorless with no particles visible. Always make sure you have the correct insulin before each injection.
While using SEMGLEE, do not drive or operate heavy machinery until you know how SEMGLEE affects you. You should not drink alcohol or use other medicines that contain alcohol.

Other possible side effects may include swelling, weight gain, low potassium levels, injection site reactions, including changes in fat tissue at the injection site, and allergic reactions.

Important Safety Information for SEMGLEE (insulin glargine-yfgn) injection pen

SEMGLEE pen is a disposable single-patient-use prefilled insulin pen. Please talk to your healthcare provider about proper injection technique and follow instructions in the Instruction Leaflet that accompanies the pen.

These are not all the possible side effects of SEMGLEE. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

This summary does not include all the information about SEMGLEE and is not meant to take the place of a discussion with your healthcare provider about your treatment.